80
Participants
Start Date
July 14, 2022
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2025
Dabrafenib 75 MG
Refer arm description
Trametinib 2 MG
Refer arm description
RECRUITING
Austin Health, Heidelberg
NOT_YET_RECRUITING
Eastern Health, Box Hill
RECRUITING
Monash Health, Clayton
RECRUITING
Royal Brisbane and Women's Hospital, Brisbane
RECRUITING
Royal North Shore Hospital, Sydney
RECRUITING
Royal Adelaide Hsopital, Adelaide
NOT_YET_RECRUITING
Alfred Hospital, Prahran
RECRUITING
Sir Charles Gairdner Hospital, Perth
RECRUITING
Peter MacCallum Cancer Centre, Melbourne
Collaborators (3)
Royal North Shore Hospital
OTHER
Austin Health
OTHER_GOV
Sir Charles Gairdner Hospital
OTHER
Monash Health
OTHER
Peter MacCallum Cancer Centre, Australia
OTHER
Royal Brisbane and Women's Hospital
OTHER_GOV
Eastern Health
OTHER
The Alfred
OTHER
Royal Adelaide Hospital
OTHER
Olivia Newton-John Cancer Research Institute
OTHER